Progress in the preparation and testing of glycine transporter type-1 (GlyT1) inhibitors

CW Lindsley, SE Wolkenberg… - Current Topics in …, 2006 - ingentaconnect.com
Clinically utilized antipsychotic agents share as a common mechanism the ability to
antagonize dopamine D2 receptors and it is widely assumed that this activity contributes to …
被引用次数：72 相关文章

Progress in the preparation and testing of glycine transporter type-1 (GlyT1) inhibitors.

CW Lindsley, SE Wolkenberg… - Current Topics in …, 2006 - europepmc.org
Clinically utilized antipsychotic agents share as a common mechanism the ability to
antagonize dopamine D2 receptors and it is widely assumed that this activity contributes to …

Progress in the preparation and testing of glycine transporter type-1 (GlyT1) inhibitors

CW Lindsley, SE Wolkenberg… - Current topics in …, 2006 - pubmed.ncbi.nlm.nih.gov
Clinically utilized antipsychotic agents share as a common mechanism the ability to
antagonize dopamine D2 receptors and it is widely assumed that this activity contributes to …